SZLS Stock Price, Chart, Stats & News

StageZero Life Sciences Ltd.
Save
StageZero Life Sciences Ltd. (SZLS) does not currently pay a dividend.
4.94M
Market cap
–
Current P/E
3.37x
Forward P/E
SZLS chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples.
Similar securities
Based on sector and market capitalization
Report issue











